Webinar
Navigating the Early Asset Evaluation Journey with Confidence
3 Sessions Available: February 25‑26, 2025
February 25 – 1:00 PM ET
February 26 – 16:00 (UTC +8:00) – Asia/Shanghai
February 26 – 15:00 CET – Europe/Berlin
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle.
Join a team of cross-functional experts from Trinity Life Sciences for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives. The team will share real-life examples highlighting what life sciences companies need to be thinking about and common pitfalls they must avoid to navigate the early asset evaluation journey with confidence.
Key Webinar Topics
- What are the critical questions along the asset evaluation journey?
- How do you identify which indication to prioritize to maximize value?
- To what extent do you enable R&D vs. Commercial to drive the decision?
- How can you drive smart, lean insights and analytics for a new asset?
- When and how do you typically consider regionality in the process?
